GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acacia Research Corporation (ACTG) [hlAlert]

Rating:
Buy ACTG
down 58.73 %

Acacia Research Corporation (ACTG) rated Buy with price target $33 by Standpoint Research

Posted on: Tuesday,  Sep 17, 2013  12:25 PM ET by Standpoint Research

Standpoint Research rated Buy Acacia Research Corporation (NASDAQ: ACTG) on 09/17/2013, when the stock price was $22.61. Since
then, Acacia Research Corporation has lost 58.74% as of 12/23/2015's recent price of $9.33.
If you would have followed this Standpoint Research's recommendation on ACTG, you would have lost 58.73% of your investment in 827 days.

Acacia Research- Acacia Technologies is a division of Acacia Research Corporation. The Company acquires, develops, licenses and enforces patented technologies. The Company generates license fee revenues and related cash flow from the granting of non-exclusive licenses for the use of its patented technologies. The Acacia Technologies group assists patent holders with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, if necessary, with the enforcement against unauthorized users of their patented technologies.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/17/2013 12:25 PM Buy
None
22.61 33.00
as of 12/13/2013
1 Week down  -7.14 %
1 Month down  -12.14 %
3 Months down  -43.69 %
1 YTD down  -43.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy